Analysts Set Akero Therapeutics, Inc. (NASDAQ:AKRO) Price Target at $41.13
Akero Therapeutics, Inc. (NASDAQ:AKRO – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the nine research firms that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12-month […]
More Stories
Robert S. Ellin Buys 9,055 Shares of PodcastOne, Inc. (NASDAQ:PODC) Stock
PodcastOne, Inc. (NASDAQ:PODC – Get Free Report) Chairman Robert S. Ellin purchased 9,055 shares of the business’s stock in a...
Insider Buying: George Weston Limited (TSE:WN) Senior Officer Acquires 1,000 Shares of Stock
George Weston Limited (TSE:WN – Get Free Report) Senior Officer Rashid Wasti acquired 1,000 shares of the business’s stock in...
Insider Buying: Wellnex Life Limited (ASX:WNX) Insider Purchases 1,190,593 Shares of Stock
Wellnex Life Limited (ASX:WNX – Get Free Report) insider Zlatko (Zack) Bozinovski purchased 1,190,593 shares of the firm’s stock in...
Richard William Scalzo Sells 1,390 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) Stock
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) SVP Richard William Scalzo sold 1,390 shares of the stock in a...
Ted Yednock Sells 4,500 Shares of Annexon, Inc. (NASDAQ:ANNX) Stock
Annexon, Inc. (NASDAQ:ANNX – Get Free Report) EVP Ted Yednock sold 4,500 shares of the firm’s stock in a transaction...
Analysts Set Par Pacific Holdings, Inc. (NYSE:PARR) Price Target at $33.17
Shares of Par Pacific Holdings, Inc. (NYSE:PARR – Get Free Report) have been given an average rating of “Hold” by...